Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients
Rev Esp Cardiol (Engl Ed). 2021 Jan;74(1):108-111.
doi: 10.1016/j.rec.2020.08.020.
Epub 2020 Oct 1.
[Article in
English,
Spanish]
Affiliations
- 1 Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain. Electronic address: ama_garcia@hotmail.com.
- 2 Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
- 3 Departamento de Endocrinología y Nutrición, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain; Departamento de Medicina Clínica, Universidad Miguel Hernández, Elche, Alicante, Spain.
No abstract available
MeSH terms
-
Aged
-
Anti-Bacterial Agents / adverse effects
-
Anti-Bacterial Agents / therapeutic use
-
Antimalarials / adverse effects
-
Antimalarials / therapeutic use
-
Azithromycin / adverse effects*
-
Azithromycin / therapeutic use
-
COVID-19 / epidemiology
-
COVID-19 Drug Treatment*
-
Drug Therapy, Combination
-
Electrocardiography / drug effects
-
Electrocardiography / methods*
-
Female
-
Humans
-
Hydroxychloroquine / adverse effects*
-
Hydroxychloroquine / therapeutic use
-
Long QT Syndrome / chemically induced
-
Long QT Syndrome / diagnosis*
-
Long QT Syndrome / physiopathology
-
SARS-CoV-2
Substances
-
Anti-Bacterial Agents
-
Antimalarials
-
Hydroxychloroquine
-
Azithromycin